大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Colorectal Cancer Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-15584 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、121ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、大腸がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。大腸がん治療の種類別市場規模（診断、治療）、用途別市場規模（病院、クリニック、研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Taiho Pharma、Regeneron、Takeda、Merck KGaA、Sanofi、Amgen、Onyx、Eli Lilly、Roche、Bayer、Jiangsu Hengrui Medicine、Bristol-Myers Squib、Jiangsu Chia-Tai Tianqing、Hutchison MediPharma、Sumitomo Dainippon Pharma、Suzhou Zelgen Biopharmaceuticals、Array BioPharma ・地域別グローバル市場分析 2015年-2020年 ・大腸がん治療の北米市場（アメリカ、カナダ、メキシコ） ・大腸がん治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・大腸がん治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・大腸がん治療の南米市場（ブラジル、アルゼンチン） ・大腸がん治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：診断、治療 ・用途別分析：病院、クリニック、研究機関 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Colorectal Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 15020 million by 2025, from USD 12490 million in 2019.

The Colorectal Cancer Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Colorectal Cancer Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Colorectal Cancer Therapeutics market has been segmented into:
Diagnostics
Therapeutics

By Application, Colorectal Cancer Therapeutics has been segmented into:
Hospitals
Clinic
Research institutions

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Colorectal Cancer Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Colorectal Cancer Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Colorectal Cancer Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Colorectal Cancer Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Colorectal Cancer Therapeutics Market Share Analysis
Colorectal Cancer Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Colorectal Cancer Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Colorectal Cancer Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Colorectal Cancer Therapeutics are:
Taiho Pharma
Regeneron
Takeda
Merck KGaA
Sanofi
Amgen
Onyx
Eli Lilly
Roche
Bayer
Jiangsu Hengrui Medicine
Bristol-Myers Squib
Jiangsu Chia-Tai Tianqing
Hutchison MediPharma
Sumitomo Dainippon Pharma
Suzhou Zelgen Biopharmaceuticals
Array BioPharma

レポート目次

---

Table of Contents

1 Colorectal Cancer Therapeutics Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Therapeutics
1.2 Classification of Colorectal Cancer Therapeutics by Type
1.2.1 Global Colorectal Cancer Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Type in 2019
1.2.3 Diagnostics
1.2.4 Therapeutics
1.3 Global Colorectal Cancer Therapeutics Market by Application
1.3.1 Overview: Global Colorectal Cancer Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Research institutions
1.4 Global Colorectal Cancer Therapeutics Market by Regions
1.4.1 Global Colorectal Cancer Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Colorectal Cancer Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Colorectal Cancer Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Colorectal Cancer Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colorectal Cancer Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Colorectal Cancer Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colorectal Cancer Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Taiho Pharma
2.1.1 Taiho Pharma Details
2.1.2 Taiho Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Taiho Pharma SWOT Analysis
2.1.4 Taiho Pharma Product and Services
2.1.5 Taiho Pharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Regeneron
2.2.1 Regeneron Details
2.2.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Regeneron SWOT Analysis
2.2.4 Regeneron Product and Services
2.2.5 Regeneron Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck KGaA SWOT Analysis
2.4.4 Merck KGaA Product and Services
2.4.5 Merck KGaA Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen SWOT Analysis
2.6.4 Amgen Product and Services
2.6.5 Amgen Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Onyx
2.7.1 Onyx Details
2.7.2 Onyx Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Onyx SWOT Analysis
2.7.4 Onyx Product and Services
2.7.5 Onyx Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Jiangsu Hengrui Medicine
2.11.1 Jiangsu Hengrui Medicine Details
2.11.2 Jiangsu Hengrui Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Jiangsu Hengrui Medicine SWOT Analysis
2.11.4 Jiangsu Hengrui Medicine Product and Services
2.11.5 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bristol-Myers Squib
2.12.1 Bristol-Myers Squib Details
2.12.2 Bristol-Myers Squib Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bristol-Myers Squib SWOT Analysis
2.12.4 Bristol-Myers Squib Product and Services
2.12.5 Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Jiangsu Chia-Tai Tianqing
2.13.1 Jiangsu Chia-Tai Tianqing Details
2.13.2 Jiangsu Chia-Tai Tianqing Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Jiangsu Chia-Tai Tianqing SWOT Analysis
2.13.4 Jiangsu Chia-Tai Tianqing Product and Services
2.13.5 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hutchison MediPharma
2.14.1 Hutchison MediPharma Details
2.14.2 Hutchison MediPharma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hutchison MediPharma SWOT Analysis
2.14.4 Hutchison MediPharma Product and Services
2.14.5 Hutchison MediPharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sumitomo Dainippon Pharma
2.15.1 Sumitomo Dainippon Pharma Details
2.15.2 Sumitomo Dainippon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Sumitomo Dainippon Pharma SWOT Analysis
2.15.4 Sumitomo Dainippon Pharma Product and Services
2.15.5 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Suzhou Zelgen Biopharmaceuticals
2.16.1 Suzhou Zelgen Biopharmaceuticals Details
2.16.2 Suzhou Zelgen Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Suzhou Zelgen Biopharmaceuticals SWOT Analysis
2.16.4 Suzhou Zelgen Biopharmaceuticals Product and Services
2.16.5 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Array BioPharma
2.17.1 Array BioPharma Details
2.17.2 Array BioPharma Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Array BioPharma SWOT Analysis
2.17.4 Array BioPharma Product and Services
2.17.5 Array BioPharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Colorectal Cancer Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Colorectal Cancer Therapeutics Players Market Share
3.2.2 Top 10 Colorectal Cancer Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Colorectal Cancer Therapeutics Revenue and Market Share by Regions
4.2 North America Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Colorectal Cancer Therapeutics Revenue by Countries
5.1 North America Colorectal Cancer Therapeutics Revenue by Countries (2015-2020)
5.2 USA Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Colorectal Cancer Therapeutics Revenue by Countries
6.1 Europe Colorectal Cancer Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Colorectal Cancer Therapeutics Revenue by Countries
7.1 Asia-Pacific Colorectal Cancer Therapeutics Revenue by Countries (2015-2020)
7.2 China Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Colorectal Cancer Therapeutics Revenue by Countries
8.1 South America Colorectal Cancer Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Colorectal Cancer Therapeutics by Countries
9.1 Middle East & Africa Colorectal Cancer Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Colorectal Cancer Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Colorectal Cancer Therapeutics Market Forecast by Type (2019-2024)
10.3 Diagnostics Revenue Growth Rate (2015-2025)
10.4 Therapeutics Revenue Growth Rate (2015-2025)
11 Global Colorectal Cancer Therapeutics Market Segment by Application
11.1 Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Colorectal Cancer Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Research institutions Revenue Growth (2015-2020)
12 Global Colorectal Cancer Therapeutics Market Size Forecast (2021-2025)
12.1 Global Colorectal Cancer Therapeutics Market Size Forecast (2021-2025)
12.2 Global Colorectal Cancer Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Colorectal Cancer Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Colorectal Cancer Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Colorectal Cancer Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Colorectal Cancer Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Taiho Pharma Corporate Information, Location and Competitors
Table 6. Taiho Pharma Colorectal Cancer Therapeutics Major Business
Table 7. Taiho Pharma Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Taiho Pharma SWOT Analysis
Table 9. Taiho Pharma Colorectal Cancer Therapeutics Product and Solutions
Table 10. Taiho Pharma Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Regeneron Corporate Information, Location and Competitors
Table 12. Regeneron Colorectal Cancer Therapeutics Major Business
Table 13. Regeneron Colorectal Cancer Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Regeneron SWOT Analysis
Table 15. Regeneron Colorectal Cancer Therapeutics Product and Solutions
Table 16. Regeneron Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Takeda Corporate Information, Location and Competitors
Table 18. Takeda Colorectal Cancer Therapeutics Major Business
Table 19. Takeda Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Takeda SWOT Analysis
Table 21. Takeda Colorectal Cancer Therapeutics Product and Solutions
Table 22. Takeda Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck KGaA Corporate Information, Location and Competitors
Table 24. Merck KGaA Colorectal Cancer Therapeutics Major Business
Table 25. Merck KGaA Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Merck KGaA SWOT Analysis
Table 27. Merck KGaA Colorectal Cancer Therapeutics Product and Solutions
Table 28. Merck KGaA Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Colorectal Cancer Therapeutics Major Business
Table 31. Sanofi Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Colorectal Cancer Therapeutics Product and Solutions
Table 34. Sanofi Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Amgen Corporate Information, Location and Competitors
Table 36. Amgen Colorectal Cancer Therapeutics Major Business
Table 37. Amgen Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Amgen SWOT Analysis
Table 39. Amgen Colorectal Cancer Therapeutics Product and Solutions
Table 40. Amgen Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Onyx Corporate Information, Location and Competitors
Table 42. Onyx Colorectal Cancer Therapeutics Major Business
Table 43. Onyx Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Onyx SWOT Analysis
Table 45. Onyx Colorectal Cancer Therapeutics Product and Solutions
Table 46. Onyx Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Colorectal Cancer Therapeutics Major Business
Table 49. Eli Lilly Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Colorectal Cancer Therapeutics Product and Solutions
Table 52. Eli Lilly Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Colorectal Cancer Therapeutics Major Business
Table 55. Roche Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Colorectal Cancer Therapeutics Product and Solutions
Table 58. Roche Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bayer Corporate Information, Location and Competitors
Table 60. Bayer Colorectal Cancer Therapeutics Major Business
Table 61. Bayer Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Bayer SWOT Analysis
Table 63. Bayer Colorectal Cancer Therapeutics Product and Solutions
Table 64. Bayer Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Jiangsu Hengrui Medicine Corporate Information, Location and Competitors
Table 66. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Major Business
Table 67. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Jiangsu Hengrui Medicine SWOT Analysis
Table 69. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product and Solutions
Table 70. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Bristol-Myers Squib Corporate Information, Location and Competitors
Table 72. Bristol-Myers Squib Colorectal Cancer Therapeutics Major Business
Table 73. Bristol-Myers Squib Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. Bristol-Myers Squib SWOT Analysis
Table 75. Bristol-Myers Squib Colorectal Cancer Therapeutics Product and Solutions
Table 76. Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Jiangsu Chia-Tai Tianqing Corporate Information, Location and Competitors
Table 78. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Major Business
Table 79. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 80. Jiangsu Chia-Tai Tianqing SWOT Analysis
Table 81. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product and Solutions
Table 82. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Hutchison MediPharma Corporate Information, Location and Competitors
Table 84. Hutchison MediPharma Colorectal Cancer Therapeutics Major Business
Table 85. Hutchison MediPharma Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 86. Hutchison MediPharma SWOT Analysis
Table 87. Hutchison MediPharma Colorectal Cancer Therapeutics Product and Solutions
Table 88. Hutchison MediPharma Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Sumitomo Dainippon Pharma Corporate Information, Location and Competitors
Table 90. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Major Business
Table 91. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 92. Sumitomo Dainippon Pharma SWOT Analysis
Table 93. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product and Solutions
Table 94. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Suzhou Zelgen Biopharmaceuticals Corporate Information, Location and Competitors
Table 96. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Major Business
Table 97. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 98. Suzhou Zelgen Biopharmaceuticals SWOT Analysis
Table 99. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product and Solutions
Table 100. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Array BioPharma Corporate Information, Location and Competitors
Table 102. Array BioPharma Colorectal Cancer Therapeutics Major Business
Table 103. Array BioPharma Colorectal Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 104. Array BioPharma SWOT Analysis
Table 105. Array BioPharma Colorectal Cancer Therapeutics Product and Solutions
Table 106. Array BioPharma Colorectal Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Colorectal Cancer Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 108. Global Colorectal Cancer Therapeutics Revenue Share by Players (2015-2020)
Table 109. Global Colorectal Cancer Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Colorectal Cancer Therapeutics Revenue Market Share by Regions (2015-2020)
Table 111. North America Colorectal Cancer Therapeutics Revenue by Countries (2015-2020)
Table 112. North America Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Table 113. Europe Colorectal Cancer Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Colorectal Cancer Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Colorectal Cancer Therapeutics Revenue by Countries (2015-2020)
Table 116. South America Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Colorectal Cancer Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Table 119. Global Colorectal Cancer Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 120. Global Colorectal Cancer Therapeutics Revenue Share by Type (2015-2020)
Table 121. Global Colorectal Cancer Therapeutics Revenue Forecast by Type (2021-2025)
Table 122. Global Colorectal Cancer Therapeutics Revenue by Application (2015-2020)
Table 123. Global Colorectal Cancer Therapeutics Revenue Share by Application (2015-2020)
Table 124. Global Colorectal Cancer Therapeutics Revenue Forecast by Application (2021-2025)
Table 125. Global Colorectal Cancer Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Colorectal Cancer Therapeutics Picture
Figure 2. Global Colorectal Cancer Therapeutics Revenue Market Share by Type in 2019
Figure 3. Diagnostics Picture
Figure 4. Therapeutics Picture
Figure 5. Colorectal Cancer Therapeutics Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinic Picture
Figure 8. Research institutions Picture
Figure 9. Global Colorectal Cancer Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Colorectal Cancer Therapeutics Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Colorectal Cancer Therapeutics Revenue Market Share in 2019
Figure 18. Global Top 10 Players Colorectal Cancer Therapeutics Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Colorectal Cancer Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 22. Global Colorectal Cancer Therapeutics Revenue Market Share by Regions in 2018
Figure 23. North America Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 24. Europe Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. South America Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. North America Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 29. North America Colorectal Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 30. USA Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Canada Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Europe Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Colorectal Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 35. Germany Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. UK Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. France Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Russia Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Italy Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Colorectal Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 42. China Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Japan Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Korea Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. India Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. South America Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 48. South America Colorectal Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 49. Brazil Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Colorectal Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Colorectal Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. UAE Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Colorectal Cancer Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Global Colorectal Cancer Therapeutics Revenue Share by Type (2015-2020)
Figure 58. Global Colorectal Cancer Therapeutics Revenue Share by Type in 2019
Figure 59. Global Colorectal Cancer Therapeutics Market Share Forecast by Type (2021-2025)
Figure 60. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 61. Global Therapeutics Revenue Growth Rate (2015-2020)
Figure 62. Global Colorectal Cancer Therapeutics Revenue Share by Application (2015-2020)
Figure 63. Global Colorectal Cancer Therapeutics Revenue Share by Application in 2019
Figure 64. Global Colorectal Cancer Therapeutics Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Research institutions Revenue Growth Rate (2015-2020)
Figure 68. Global Colorectal Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Colorectal Cancer Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Colorectal Cancer Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
Figure 72. Europe Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. South America Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Colorectal Cancer Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---